Target intelligence / Profile preview

General cellular lipid and membrane compartments

Molecular classification
Other
01

Overview

General cellular lipid and membrane compartments refer to the complex lipid bilayers and associated hydrophobic environments that constitute the structural boundaries of cells and organelles. These compartments are primarily composed of phospholipids, cholesterol, and sphingolipids, which provide a semi-permeable barrier and a matrix for membrane protein function (van Meer et al., 2008). While not a single molecular entity, they serve as critical therapeutic targets for various agents, particularly anti-infectives that exploit differences between host and pathogen membrane compositions (Epand & Epand, 2009). For example, certain antibiotics like daptomycin and antifungals like amphotericin B disrupt membrane integrity or form pores, leading to rapid cell death (Baginski & Tugnoli, 2005). Additionally, the physical state of the membrane, such as its fluidity and thickness, can modulate the activity of embedded receptors and ion channels (Franks, 2008). This makes the membrane a secondary or even primary target for lipophilic drugs like general anesthetics, which may alter the lateral pressure profile of the bilayer (Cantor, 1997). In disease states, changes in membrane lipid composition can lead to signaling dysregulation or increased susceptibility to oxidative stress (Maxfield & Tabas, 2005).

Other names
Biological membraneLipid bilayerPlasma membraneCellular lipidsMembrane lipidsCytoplasmic membrane
02

Mechanism of action

Drugs targeting these compartments typically act through physical disruption of the lipid bilayer, alteration of membrane fluidity, formation of transmembrane pores, or sequestration of specific lipid species like ergosterol or phosphatidylglycerol (Baginski & Tugnoli, 2005; Epand & Epand, 2009).

03

Biological functions

CompartmentalizationSignal transductionBarrier functionMolecular transportCellular homeostasis
04

Disease associations

InfectionCancerNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Lack of cellular specificityPotential for systemic toxicityHemolysisOff-target effects on host cell membranesNephrotoxicity
06

Interacting drugs

Amphotericin B

6 more in the full profile.

07

Biomarkers

Lipidomic profileMembrane fluidity indexMalondialdehyde (MDA) levels4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on General cellular lipid and membrane compartments.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular lipid and membrane compartments.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call